paclitaxel has been researched along with Hashimoto Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellanger, C; Classe, M; Even, C; Garcia, G; Saleh, K | 1 |
1 other study(ies) available for paclitaxel and Hashimoto Disease
| Article | Year |
|---|---|
Complete response upon salvage chemotherapy after anti-PD1 failure: Watch and wait.
Topics: Adult; Antineoplastic Agents, Immunological; Colitis, Ulcerative; Hashimoto Disease; Humans; Immune Checkpoint Inhibitors; Male; Nivolumab; Paclitaxel; Programmed Cell Death 1 Receptor; Remission Induction; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tongue Neoplasms; Treatment Failure | 2021 |